{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:37:42Z","timestamp":1789641462161,"version":"4.0.0"},"reference-count":7,"publisher":"Centers for Disease Control MMWR Office","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7037a5","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:47:38Z","timestamp":1631800058000},"page":"1303-1304","source":"Crossref","is-referenced-by-count":54,"title":["<i>Notes from the Field<\/i>: Xylazine, a Veterinary Tranquilizer, Identified as an Emerging Novel Substance in Drug Overdose Deaths \u2014 Connecticut, 2019\u20132020"],"prefix":"10.15585","volume":"70","author":[{"given":"Shobha","family":"Thangada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/jat\/bkw051","article-title":"The never-ending public health issue of adulterants in abused drugs.","volume":"40","author":"Busard\u00f2","year":"2016","journal-title":"J Anal Toxicol"},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health"},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico.","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R4","first-page":"47","article-title":"Accidental self-injection of xylazine during work: a rare case.","volume":"12","author":"Ganapathy","year":"2018","journal-title":"Borneo J Med Sci."},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/15563650.2018.1450986","article-title":"Naloxone reversal of clonidine toxicity: dose, dose, dose.","volume":"56","author":"Seger","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","article-title":"Severe intoxication from xylazine inhalation.","volume":"17","author":"Capraro","year":"2001","journal-title":"Pediatr Emerg Care"},{"key":"key-10.15585\/mmwr.mm7037a5-202109160919-R7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/15563650601073520","article-title":"Xylazine abuse: a rare cause of syncope.","volume":"45(3)","author":"Liu","year":"2007","journal-title":"Clin Toxicol"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:47:41Z","timestamp":1631800061000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7037a5.htm?s_cid=mm7037a5_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":7,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2021,9,17]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7037a5","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,17]]},"published":{"date-parts":[[2021,9,17]]}}}